To access the full text documents, please follow this link: http://hdl.handle.net/10230/924
dc.contributor | Universitat Pompeu Fabra. Departament d'Economia i Empresa |
---|---|
dc.contributor.author | Puig i Junoy, Jaume |
dc.date | 2005-12-01 |
dc.identifier.citation | https://econ-papers.upf.edu/ca/paper.php?id=906 |
dc.identifier.uri | http://hdl.handle.net/10230/924 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.relation | Economics and Business Working Papers Series; 906 |
dc.rights | L'accés als continguts d'aquest document queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ |
dc.subject | Labour, Public, Development and Health Economics |
dc.subject | pharmaceutical sales |
dc.subject | generic medicines |
dc.subject | pharmaceutical reference pricing |
dc.subject | statins |
dc.title | The impact of generic reference pricing interventions in the statin market |
dc.type | info:eu-repo/semantics/workingPaper |